...

首页> 外文期刊>Circulation: An Official Journal of the American Heart Association >On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF (vol 134, pg 37, 2016)

【24h】

On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF (vol 134, pg 37, 2016)

机译：利伐沙班与华法林相比肾功能恶化患者的治疗结局：ROCKET AF的见解（第134卷，第37页，2016年）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Circulation: An Official Journal of the American Heart Association》 |2016年第8期|共1页
作者
Fordyce;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词

相似文献

外文文献
中文文献
专利

1. On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF (vol 134, pg 37, 2016) [J] . Fordyce Circulation: An Official Journal of the American Heart Association . 2016,第8期

机译：利伐沙班与华法林相比肾功能恶化患者的治疗结局：ROCKET AF的见解（第134卷，第37页，2016年）
2. On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin Insights From ROCKET AF [J] . Fordyce Christopher B., Hellkamp Anne S., Lokhnygina Yuliya, Circulation: An Official Journal of the American Heart Association . 2016,第1期

机译：利伐沙班治疗肾功能恶化患者的治疗结果与ROCKET AF对华法林的比较
3. Letter by Escobar et al Regarding Article, "On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF" [J] . Escobar Carlos, Barrios Vivencio, Gorriz Jose Luis Circulation: An Official Journal of the American Heart Association . 2016,第22期

机译：Escobar等人关于文章的信，“与使用华法林相比，利伐沙班肾功能恶化的患者的治疗结局：ROCKET AF的见解”
4. Prediction of Patient Outcomes after Renal Replacement Therapy in Intensive Care [C] . Harry F. da Cruz, Siegfried Horschig, Christian Nusshag, International Conference on Informatics and Assistive Technologies for Health-Care, Medical Support and Wellbeing . 2018

机译：重症监护肾置换疗法后患者结果预测
5. Blood-Pressure Reduction is Associated With Worsening in Renal Function but Does Not Prevent Successful Decongestion in Patients Treated for Acute Decompensated Heart Failure. [D] . Kula, Alexander James. 2015

机译：降压与肾功能恶化有关，但不能阻止接受急性代偿性心力衰竭治疗的患者成功消退。
6. Efficacy and safety of rivaroxaban compared with warfarin in patients with carotid artery disease and nonvalvular atrial fibrillation: Insights from the ROCKET AF trial [O] . Ajar Kochar, Anne S. Hellkamp, Yuliya Lokhnygina, 2018

机译：利伐沙班与华法林相比在颈动脉疾病和非瓣膜性心房颤动患者中的疗效和安全性：ROCKET AF试验的启示
7. Correction to: On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF [O] . 2020

机译：与Rivaroxaban的肾功能恶化的患者的治疗结果纠正：来自华法林的肾功能：来自火箭AF的见解

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号